Market Overview:
The global research antibodies market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for research antibodies from academic and research institutes, contract research organizations (CROs), and pharmaceutical and biotechnology companies. The monoclonal antibodies segment is expected to dominate the global market in terms of revenue during the forecast period. However, the polyclonal antibodies segment is projected to grow at a higher CAGR than that of monoclonal antibodies during the forecast period.
Product Definition:
Research antibodies are laboratory-made proteins that bind to a specific target, such as a protein or DNA sequence. They can be used to detect and identify the presence of that target in biological samples. Research antibodies can also be used to study the function of the target protein or gene.
Monoclonal Antibodies:
Monoclonal antibodies are antibody molecules, which are manufactured by the human body specifically for a particular disease. There is an ongoing research on monoclonal antibodies in the pharmaceutical industry as there are many advantages associated with it such as it has greater therapeutic effects and also less side effects. Monoclonal Antibodies have various applications in cancer treatment, blood disorders diagnosis & research and autoimmune diseases treatment.
Polyclonal Antibodies:
Polyclonal antibodies are made by B cells and are used in research for the detection of antigens. They have several advantages over monoclonal antibodies such as they can be produced by different species, they do not require a constant source of supply, and their use does not require a high level of expertise.
Application Insights:
The academic and research institutes segment held the largest share of over 60.0% in 2017. The presence of a large number of research organizations in each region has contributed to the largest share being held by this segment. In addition, factors such as increasing government funding for R&D have played a key role in driving growth for this segment.
The contract research organization (CRO) is another important application that drives market growth owing to its ability to deliver high quality products at lower costs than the traditional methodologies used across the globe.
Regional Analysis:
North America dominated the global research antibodies market in terms of revenue share in 2017. This is due to the presence of a large number of CROs and universities/ institutes that are engaged in R&D activities. The U.S., being one of the most developed nations, leads this region with high spending on healthcare and medical research coupled with technological advancements. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing investments by governments as well as private entities for developing novel therapies for diseases prevalent within their countries.
The key players operating in this industry are AbbVie Inc.; Celgene Corporation; FUJIFILM Diosynth Biotechnologies ULC; Janssen Sciences LLC; Merck KGaA; Pfizer Inc.; Roche AG & Co.; Santa Cruz Biotechnology Ltd.
Growth Factors:
- Increasing demand for monoclonal antibodies in research and therapeutic applications
- Growing prevalence of chronic diseases that require regular monitoring and treatment, which is driving the demand for diagnostic tests that use antibodies
- Rising number of biotech and pharmaceutical companies engaged in antibody-based drug discovery programs
- Proliferation of targeted cancer therapies, which are reliant on tumor-specific antibodies for diagnosis and treatment
- Advances in antibody engineering technologies that are making it possible to create novel therapeutics with improved efficacy and fewer side effects
Scope Of The Report
Report Attributes
Report Details
Report Title
Research Antibodies Market Research Report
By Type
Monoclonal Antibodies, Polyclonal Antibodies
By Application
Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies
By Companies
Abcam PLC, Agilent Technologies, Thermo Fisher Scientific, Inc., Bio - Rad Laboratories, Merck Millipore (Danaher), Lonza Group, F.Hoffmann La Roche Ltd., Cell Signalling Technology, Inc., PerkinElmer, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Research Antibodies Market Report Segments:
The global Research Antibodies market is segmented on the basis of:
Types
Monoclonal Antibodies, Polyclonal Antibodies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam PLC
- Agilent Technologies
- Thermo Fisher Scientific, Inc.
- Bio - Rad Laboratories
- Merck Millipore (Danaher)
- Lonza Group
- F.Hoffmann La Roche Ltd.
- Cell Signalling Technology, Inc.
- PerkinElmer, Inc.
Highlights of The Research Antibodies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
- By Application:
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Research Antibodies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Research antibodies are proteins that are created in a laboratory to help scientists study the effects of certain diseases or chemicals on cells.
Some of the major players in the research antibodies market are Abcam PLC, Agilent Technologies, Thermo Fisher Scientific, Inc., Bio - Rad Laboratories, Merck Millipore (Danaher), Lonza Group, F.Hoffmann La Roche Ltd., Cell Signalling Technology, Inc., PerkinElmer, Inc..
The research antibodies market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Research Antibodies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Research Antibodies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Research Antibodies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Research Antibodies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Research Antibodies Market Size & Forecast, 2018-2028
4.5.1 Research Antibodies Market Size and Y-o-Y Growth
4.5.2 Research Antibodies Market Absolute $ Opportunity
Chapter 5 Global Research Antibodies Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Research Antibodies Market Size Forecast by Type
5.2.1 Monoclonal Antibodies
5.2.2 Polyclonal Antibodies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Research Antibodies Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Research Antibodies Market Size Forecast by Applications
6.2.1 Academic & Research Institutes
6.2.2 Contract Research Organizations
6.2.3 Pharmaceutical & Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Research Antibodies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Research Antibodies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Research Antibodies Analysis and Forecast
9.1 Introduction
9.2 North America Research Antibodies Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Research Antibodies Market Size Forecast by Type
9.6.1 Monoclonal Antibodies
9.6.2 Polyclonal Antibodies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Research Antibodies Market Size Forecast by Applications
9.10.1 Academic & Research Institutes
9.10.2 Contract Research Organizations
9.10.3 Pharmaceutical & Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Research Antibodies Analysis and Forecast
10.1 Introduction
10.2 Europe Research Antibodies Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Research Antibodies Market Size Forecast by Type
10.6.1 Monoclonal Antibodies
10.6.2 Polyclonal Antibodies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Research Antibodies Market Size Forecast by Applications
10.10.1 Academic & Research Institutes
10.10.2 Contract Research Organizations
10.10.3 Pharmaceutical & Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Research Antibodies Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Research Antibodies Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Research Antibodies Market Size Forecast by Type
11.6.1 Monoclonal Antibodies
11.6.2 Polyclonal Antibodies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Research Antibodies Market Size Forecast by Applications
11.10.1 Academic & Research Institutes
11.10.2 Contract Research Organizations
11.10.3 Pharmaceutical & Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Research Antibodies Analysis and Forecast
12.1 Introduction
12.2 Latin America Research Antibodies Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Research Antibodies Market Size Forecast by Type
12.6.1 Monoclonal Antibodies
12.6.2 Polyclonal Antibodies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Research Antibodies Market Size Forecast by Applications
12.10.1 Academic & Research Institutes
12.10.2 Contract Research Organizations
12.10.3 Pharmaceutical & Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Research Antibodies Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Research Antibodies Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Research Antibodies Market Size Forecast by Type
13.6.1 Monoclonal Antibodies
13.6.2 Polyclonal Antibodies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Research Antibodies Market Size Forecast by Applications
13.10.1 Academic & Research Institutes
13.10.2 Contract Research Organizations
13.10.3 Pharmaceutical & Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Research Antibodies Market: Competitive Dashboard
14.2 Global Research Antibodies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam PLC
14.3.2 Agilent Technologies
14.3.3 Thermo Fisher Scientific, Inc.
14.3.4 Bio - Rad Laboratories
14.3.5 Merck Millipore (Danaher)
14.3.6 Lonza Group
14.3.7 F.Hoffmann La Roche Ltd.
14.3.8 Cell Signalling Technology, Inc.
14.3.9 PerkinElmer, Inc.
